Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis

Clinical trial NCT07360808 · RECRUITING

Trial details

NCT number: NCT07360808
Sponsor: Cytori Therapeutics
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Systemic Sclerosis (SSc)Hand Dysfunction

Start date: 2025-12-31
Primary completion: 2027-12-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.